Xu Chen
No.61 Jiefang West Road
Changsha, 410005, China
Changsha, 410005, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The optimal number of examined lymph nodes for cancer specific death of intrahepatic cholangiocarcinoma: a population-based study.
Journal: Discover oncology
Published: December 23, 2024
Isorhamnetin inhibits cholangiocarcinoma proliferation and metastasis via PI3K/AKT signaling pathway.
Journal: Discover oncology
Published: October 01, 2024
Machine Learning-based Macrophage Signature for Predicting Prognosis and Immunotherapy Benefits in Cholangiocarcinoma.
Journal: Current medicinal chemistry
Published: July 19, 2024
Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinoma.
Journal: Translational oncology
Published: October 14, 2023
Molecular mechanism of Spatholobi Caulis treatment for cholangiocarcinoma based on network pharmacology, molecular docking, and molecular dynamics simulation.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: July 29, 2023
AFAP1L1 promotes gastric cancer progression by interacting with VAV2 to facilitate CDC42-mediated activation of ITGA5 signaling pathway.
Journal: Journal of translational medicine
Published: November 17, 2022
Long noncoding RNA lnc-LEMGC combines with DNA-PKcs to suppress gastric cancer metastasis.
Journal: Cancer letters
Published: January 14, 2021
Arginine methyltransferase inhibitor 1 inhibits gastric cancer by downregulating eIF4E and targeting PRMT5.
Journal: Toxicology and applied pharmacology
Published: June 12, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026